HomeOrderingContact UsAbout UsInvestor InformationSite Map

 

TRANSGENOMIC is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.
 

  WAVE® Systems and Consumables
  SURVEYOR® Mutation Detection Products
  Cytogenetics Automated Systems

  Molecular Laboratory
  Pharmacogenomic Services
   

TRANSGENOMIC technologies are highlighted in more than 1,800 peer-reviewed journal articles.


ISO 9001
FM 538914

ISO 9001:2000 Certification Transgenomic instrument and consumable product manufacturing, distribution and instrument support services at the Irvington, NE, USA facility has received ISO Certification of Registration for Quality Management.

 

 

 

 

 
What's New
Investor Presentation Investor Presentation 11/2008
Dr Cohen's interview on autism and mitochondrial diseases
International Congress of Inborn Errors of Metabolism
Aug 29 - Sep 2
Abstract - Somatic mosaicism in a patient with Lynch syndrome
Abstract - Development of a denaturing high-performance liquid chromatography method for detection of protist parasites of metazoans
Abstract - Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy
May 22 Press Releases
Transgenomic, Inc. Announces Appointment of New Board Members
May 13 Press Releases
Transgenomic, Inc. Reports First Quarter 2009 Results
May 13 Press Releases
Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
 
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2009 Transgenomic, Inc., All Rights Reserved.the power of discovery™